(redirected from Antisoma plc)
AIOAFAntisoma plc
AIOAFAll India Outdoor Advertising Federation
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Dr Elger was previously the VP, Marketing & Communications at cancer drug developer Antisoma plc (LON: ASM).
31 January 2011 - UK-based biopharmaceutical company Antisoma plc (LSE: ASM; USOTC: ATSMY) announced today that the ACCEDE Phase III trial of AS1413 (amonafide) in secondary acute myeloid leukemia (secondary AML) did not meet its primary endpoint.
30 November 2010 - UK cancer drugs maker Antisoma Plc (LON: ASM) said today it currently expects to report data from the ongoing Phase III study of AS1413 in patients with secondary acute myeloid leukaemia (secondary AML) in the first quarter of 2011, or before the previously anticipated June 2011.
29 March 2010 - UK-based biopharmaceutical company Antisoma plc (LON: ASM) announced today that the planned interim analysis of data from the ATTRACT-1 phase III trial of ASA404 in previously untreated non-small cell lung cancer (NSCLC) has shown that continuation of the trial would be futile, as there is little or no prospect of demonstrating a survival benefit with ASA404 in this setting.
18 March 2010 - UK biotechnology company Antisoma plc (LON: ASM) said today it has initiated a randomised, controlled, multi-territory, Phase IIb trial of AS1411 in patients with acute myeloid leukemia (AML).